These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 36989446)

  • 1. Economic burden related to fistulas or strictures among commercially insured patients with Crohn's disease in the United States.
    Fan Y; Zhang L; Jiménez MC; Bohn RL; Thompson JS; Brodovicz KG; Gray S; Melmed GY
    J Manag Care Spec Pharm; 2023 Apr; 29(4):400-408. PubMed ID: 36989446
    [No Abstract]   [Full Text] [Related]  

  • 2. Sustained long-term benefits of patient support program participation in immune-mediated diseases: improved medication-taking behavior and lower risk of a hospital visit.
    Fendrick AM; Brixner D; Rubin DT; Mease P; Liu H; Davis M; Mittal M
    J Manag Care Spec Pharm; 2021 Aug; 27(8):1086-1095. PubMed ID: 33843252
    [No Abstract]   [Full Text] [Related]  

  • 3. Patient Support Program Increased Medication Adherence with Lower Total Health Care Costs Despite Increased Drug Spending.
    Brixner D; Rubin DT; Mease P; Mittal M; Liu H; Davis M; Ganguli A; Fendrick AM
    J Manag Care Spec Pharm; 2019 Jul; 25(7):770-779. PubMed ID: 31081461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Burden of illness in progressive fibrosing interstitial lung disease.
    Singer D; Bengtson LGS; Conoscenti CS; Anderson AJ; Brekke L; Shetty SS; Brown KK
    J Manag Care Spec Pharm; 2022 Aug; 28(8):871-880. PubMed ID: 35876293
    [No Abstract]   [Full Text] [Related]  

  • 5. Incidence and economic burden of respiratory syncytial virus among adults in the United States: A retrospective analysis using 2 insurance claims databases.
    Mesa-Frias M; Rossi C; Emond B; Bookhart B; Anderson D; Drummond S; Wang J; Lefebvre P; Lamerato LE; Lafeuille MH
    J Manag Care Spec Pharm; 2022 Jul; 28(7):753-765. PubMed ID: 35503888
    [No Abstract]   [Full Text] [Related]  

  • 6. Health Care Costs and Resource Utilization Among Patients With Crohn's Disease With and Without Perianal Fistula.
    Chen G; Pedarla V; Null KD; Cazzetta SE; Khan QR; Schwartz DA
    Inflamm Bowel Dis; 2022 Jun; 28(6):870-877. PubMed ID: 34525184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Burden of Crohn's disease in the United States: long-term healthcare and work-loss related costs.
    Manceur AM; Ding Z; Muser E; Obando C; Voelker J; Pilon D; Kinkead F; Lafeuille MH; Lefebvre P
    J Med Econ; 2020 Oct; 23(10):1092-1101. PubMed ID: 32609019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic burden of peanut allergy in pediatric patients with evidence of reactions to peanuts in the United States.
    Blaiss MS; Meadows JA; Yu S; Robison DR; Hass SL; Norrett KE; Guerin A; Latremouille-Viau D; Tilles SA
    J Manag Care Spec Pharm; 2021 Apr; 27(4):516-527. PubMed ID: 33470880
    [No Abstract]   [Full Text] [Related]  

  • 9. Increased delay from initial concern to diagnosis of autism spectrum disorder and associated health care resource utilization and cost among children aged younger than 6 years in the United States.
    Vu M; Duhig AM; Tibrewal A; Campbell CM; Gaur A; Salomon C; Gupta A; Kruse M; Taraman S
    J Manag Care Spec Pharm; 2023 Apr; 29(4):378-390. PubMed ID: 36989447
    [No Abstract]   [Full Text] [Related]  

  • 10. Economic outcomes of antiobesity medication use among adults in the United States: A retrospective cohort study.
    Watkins S; Toliver JC; Kim N; Whitmire S; Garvey WT
    J Manag Care Spec Pharm; 2022 Oct; 28(10):1066-1079. PubMed ID: 35856489
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical and economic burdens of recurrence following nephrectomy for intermediate high- or high-risk renal cell carcinoma: A retrospective analysis of Surveillance, Epidemiology, and End Results-Medicare data.
    Sundaram M; Song Y; Rogerio JW; Zhang S; Bhattacharya R; Adejoro O; Carley C; Zhu JJ; Signorovitch J; Haas NB
    J Manag Care Spec Pharm; 2022 Oct; 28(10):1149-1160. PubMed ID: 36048895
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of clinical characteristics, health care resource utilization, and cost outcomes of hemophilia A carriers and noncarriers in the United States: A real-world comparative analysis.
    Xing S; Batt K; Kuharic M; Bullano M; Caicedo J; Chakladar S; Markan R; Farahbakhshian S
    J Manag Care Spec Pharm; 2023 Jun; 29(6):626-634. PubMed ID: 37276033
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of fistula on healthcare costs and utilization for patients with Crohn's disease treated in a managed care environment.
    Cohen RD; Waters HC; Tang B; Rahman MI
    Inflamm Bowel Dis; 2008 Dec; 14(12):1707-14. PubMed ID: 18618630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.
    Doshi JA; Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT
    J Manag Care Spec Pharm; 2014 Apr; 20(4):382-90. PubMed ID: 24684643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of cardiovascular disease on health care economic burden and resource utilization: a retrospective cohort study in adults in the United States with type 2 diabetes with or without stroke, myocardial infarction, and peripheral arterial disease.
    King A; Rajpura J; Liang Y; Paprocki Y; Uzoigwe C
    Curr Med Res Opin; 2022 Nov; 38(11):1831-1840. PubMed ID: 36134459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-world persistence, adherence, health care resource utilization, and costs in people with type 2 diabetes switching from a first-generation basal insulin to a second-generation (insulin glargine 300 U/mL) vs an alternative first-generation basal insulin.
    Wright EE; Malone DC; Trujillo JM; Gill J; Huse S; Li X; Zhou FL; Preblick R; Reid T
    J Manag Care Spec Pharm; 2022 Jun; 28(6):592-603. PubMed ID: 35352995
    [No Abstract]   [Full Text] [Related]  

  • 17. Association of Perianal Fistulas with Clinical Features and Prognosis of Crohn's Disease in Korea: Results from the CONNECT Study.
    Chun J; Im JP; Kim JW; Lee KL; Choi CH; Kim H; Cheon JH; Ye BD; Kim YH; Kim YS; Jeen YT; Han DS; Kim WH; Kim JS
    Gut Liver; 2018 Sep; 12(5):544-554. PubMed ID: 30037171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health care resource utilization and costs associated with advanced or metastatic nonsmall cell lung cancer in the United States.
    Zhang X; Beachler DC; Masters E; Liu F; Yang M; Dinh J; Jamal-Allial A; Kolitsopoulos F; Lamy FX
    J Manag Care Spec Pharm; 2022 Feb; 28(2):255-265. PubMed ID: 34854733
    [No Abstract]   [Full Text] [Related]  

  • 19. Descriptive study of the economic burden among patients with type 2 diabetes mellitus, chronic kidney disease, and chronic kidney disease and type 2 diabetes mellitus in a large US commercially insured population.
    Chung H; Crowe CL; Kong SX; Singh R; Farej R; Elliott J; Williamson T; Willey VJ
    J Manag Care Spec Pharm; 2023 Jan; 29(1):80-89. PubMed ID: 36580126
    [No Abstract]   [Full Text] [Related]  

  • 20. Mental Health Costs of Inflammatory Bowel Diseases.
    Szigethy E; Murphy SM; Ehrlich OG; Engel-Nitz NM; Heller CA; Henrichsen K; Lawton R; Meadows P; Allen JI
    Inflamm Bowel Dis; 2021 Jan; 27(1):40-48. PubMed ID: 32095835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.